A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with 68 Ga-labeled PD-L1 targeted nanobody.

MLA

Qin, Songbing, et al. “A Preclinical Study: Correlation between PD-L1 PET Imaging and the Prediction of Therapy Efficacy of MC38 Tumor with 68 Ga-Labeled PD-L1 Targeted Nanobody.” Aging, vol. 13, no. 9, Apr. 2021, pp. 13006–22. EBSCOhost, https://doi.org/10.18632/aging.202981.

APA

Qin, S., Yu, Y., Guan, H., Yang, Y., Sun, F., Sun, Y., Zhu, J., Xing, L., Yu, J., & Sun, X. (2021). A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with 68 Ga-labeled PD-L1 targeted nanobody. Aging, 13(9), 13006–13022. https://doi.org/10.18632/aging.202981

Chicago

Qin, Songbing, Yang Yu, Hui Guan, Yanling Yang, Fenghao Sun, Yan Sun, Jiaxing Zhu, Ligang Xing, Jinming Yu, and Xiaorong Sun. 2021. “A Preclinical Study: Correlation between PD-L1 PET Imaging and the Prediction of Therapy Efficacy of MC38 Tumor with 68 Ga-Labeled PD-L1 Targeted Nanobody.” Aging 13 (9): 13006–22. doi:10.18632/aging.202981.